Combining radiotherapy with targeted therapies in non-small cell lung cancer: focus on anti-EGFR, anti-ALK and anti-angiogenic agents

The combination of radiotherapy (RT) with targeted agents in non-small cell lung cancer (NSCLC) has been expected to improve the therapeutic ratio and tumor control. The EGFR blockade enhances the antitumor effect of RT. The ALK inhibition elicits anti-proliferative, pro-apoptotic and antiangiogenic...

Descripción completa

Detalles Bibliográficos
Autores principales: Wrona, Anna, Dziadziuszko, Rafał, Jassem, Jacek
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Review Article on Radiotherapy in Thoracic Malignancies
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8107745/
https://www.ncbi.nlm.nih.gov/pubmed/34012812
http://dx.doi.org/10.21037/tlcr-20-552

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8107745/
https://www.ncbi.nlm.nih.gov/pubmed/34012812
http://dx.doi.org/10.21037/tlcr-20-552

Ejemplares similares